Skip to content

Ibn sina pharma stock price

Ibn sina pharma stock price

Aug 30, 2019 · The Ibn Sina Pharmaceutical Industry Limited: IBNSINA (CSE): Stock Quote, Share Price, Chart, News & Profile Tuesday, Dec 31, 2019 The Ibn Sina Pharmaceutical Industry Ltd. CSE THE IBN SINA PHARMACEUTICALS LTD. Trading Code: IBNSINA. Scrip Code: 13013. Show all companies. Price Sensitive Information : Financial Performance : Performance Year: Basic EPS Based On: Basic EPS (restated) Based On Stock Broker. All Stock Brokers; Top 10 ITS; IPO. Fixed Price; Book Building; Fund Utilization; Ibnsina Pharma prices IPO at EGP 5.80 per share, says ... Dec 05, 2017 · IPO WATCH- Ibnsina Pharma prices IPO at EGP 5.80 per share, says institutional offering is more than 17x oversubscribed: Ibnsina Pharma announced this morning that it has concluded the book-building process and pricing of its institutional offering of c. 229 mn shares as part of its IPO on the Egyptian Exchange. The company priced at […] IBN SINA Pharmaceutical Industry (DSE:IBNSINA) - Share ... How has IBN SINA Pharmaceutical Industry's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : IBNSINA has not had significant price volatility in the past 3 months.

20 Feb 2019 demand and continue outperforming the market.” EFG Hermes put a “buy” on the company's shares with a target price of EGP 14.00 — and room 

Ibn Sina Pharmaceuticals' net sales witnessing more than 13 per cent growth at least in the last five years. In the 2018-19 financial year, its yearly turnover rose 13 per cent to Tk 526.4 crore. The Ibn Sina Pharmaceutical Industry Limited: IBNSINA (CSE ...

View Ibn Sina Pharma’s profile on LinkedIn, the world's largest professional community. Ibn Sina has 1 job listed on their profile. See the complete profile on LinkedIn and discover Ibn Sina’s connections and jobs at similar companies.

How has IBN SINA Pharmaceutical Industry's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : IBNSINA has not had significant price volatility in the past 3 months. Ibnsina Pharma News - Mubasher Info 12 December 2017 11:43 AM Ibn Sina Pharma’s stock levels up 15% in 1st trading session on EGX Cairo – Mubasher: Ibn Sina Pharma’s stock jumped 14.7%, reaching EGP 6.65, with a turnover of EGP 107.6 million, by 10:05 am Cairo time in its first trading session on the Egyptian Exchange (EGX).

Egypt's Ibn Sina Pharmaceuticals plans December IPO ...

Ibnsina Pharma offers an effective distribution model that generates value and increases return on sales to a supplier network of more than 350 public, private and multinational pharmaceutical production companies in Egypt. Company Overview - IBN SINA Pharma The IBN SINA Pharmaceutical Industry Ltd. is a leading pharmaceutical company in Bangladesh. The company was founded in the year 1983. The manufacturing facilities located at Gazipur, 56 kilometer away from the center of the capital city Dhaka, in a campus of about 15 acres of land. Ibnsina Pharma Registered Price | Markets Insider Ibnsina Pharma Registered Price: This is the Price-site for the company Ibnsina Pharma Registered on Markets Insider

Ibnsina Pharma is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in …

News and Disclosures- Ibnsina Pharma IR Price Range Announcement 22 November 2017 Ibnsina Ibnsina Pharma Announces a Stock Split of 1:4 sent a release regarding the news published on one of the websites titled "The arrest of the Managing Director of Ibn Sina Pharma due to the issue of drug monopoly". Ibnsina Pharma announces its intention to proceed with a ... regulatory reforms allowing pharmaceutical manufacturers to re-price their products. The European Bank for Reconstruction and Development (“EBRD”) is a minority shareholder of Ibnsina, having acquired a 21% stake through primary and secondary share transactions in 2015.

Apex Business WordPress Theme | Designed by Crafthemes